Medicare’s New Skin Substitute Reimbursement Rules Signal Increased Enforcement Risk
The Centers for Medicare & Medicaid Services (CMS) has implemented a fundamental change to how Medicare reimburses skin substitute products, effective January 1, 2026. While framed as a payment reform, the policy change carries significant compliance and enforcement implications for wound care clinics, physicians, suppliers, and manufacturers. For providers operating in the wound-care and regenerative […]